Хайлтын үр дүнгүүд - Joseph Muenzer

Үр дүнг сайжруулах
  1. 1
    Overview of the mucopolysaccharidoses

    Overview of the mucopolysaccharidoses -н Joseph Muenzer

    Хэвлэсэн 2011
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Early initiation of enzyme replacement therapy for the mucopolysaccharidoses

    Early initiation of enzyme replacement therapy for the mucopolysaccharidoses -н Joseph Muenzer

    Хэвлэсэн 2013
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Plain language summary of a study looking at whether genetic testing can help doctors diagnose the severity of mucopolysaccharidosis type I (MPS I)

    Plain language summary of a study looking at whether genetic testing can help doctors diagnose the severity of mucopolysaccharidosis type I (MPS I) -н Lorne A. Clarke, Roberto Giugliani, Joseph Muenzer

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Plain language summary of a study looking at the age at diagnosis and time to start of treatment in individuals with mucopolysaccharidosis type I (MPS I)

    Plain language summary of a study looking at the age at diagnosis and time to start of treatment in individuals with mucopolysaccharidosis type I (MPS I) -н Roberto Giugliani, Nicole Muschol, Mark Dant, Joseph Muenzer

    Хэвлэсэн 2022
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Purification of proline-rich proteins from parotid glands of isoproterenol-treated rats.

    Purification of proline-rich proteins from parotid glands of isoproterenol-treated rats. -н Joseph Muenzer, C Bildstein, Marie M. Gleason, Don M. Carlson

    Хэвлэсэн 1979
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Properties of proline-rich proteins from parotid glands of isoproterenol-treated rats.

    Properties of proline-rich proteins from parotid glands of isoproterenol-treated rats. -н Joseph Muenzer, C Bildstein, Marie M. Gleason, Don M. Carlson

    Хэвлэсэн 1979
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I

    Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I -н Roberto Giugliani, Nicole Muschol, Hillary A. Keenan, Mark Dant, Joseph Muenzer

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome

    The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome -н Julie B. Eisengart, Kelly King, Elsa Shapiro, C B Whitley, Joseph Muenzer

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice

    Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice -н Douglas M. McCarty, Julianne DiRosario, Kadra Gulaid, Joseph Muenzer, Haiyan Fu

    Хэвлэсэн 2009
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)

    Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS) -н Joseph Muenzer, Roberto Giugliani, Maurizio Scarpa, Anna Tylki‐Szymańska, Virginie Jego, Michael Beck

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS)

    Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome... -н Joseph Muenzer, Jaco Botha, Paul Harmatz, Roberto Giugliani, Christoph Kampmann, Barbara K. Burton

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome Survey registries

    Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome... -н Deborah Elstein, Roberto Giugliani, Joseph Muenzer, Jörn Schenk, Ida Vanessa Döederlein Schwartz, Christina Anagnostopoulou

    Хэвлэсэн 2021
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Initial report from the Hunter Outcome Survey

    Initial report from the Hunter Outcome Survey -н J. E. Wraith, Michael Beck, Roberto Giugliani, Joe T.R. Clarke, Rick Martin, Joseph Muenzer

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    The natural history of MPS I: global perspectives from the MPS I Registry

    The natural history of MPS I: global perspectives from the MPS I Registry -н Michael Beck, Pamela Arn, Roberto Giugliani, Joseph Muenzer, Torayuki Okuyama, J. Michael Taylor, Shari Fallet

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Neurological Correction of Lysosomal Storage in a Mucopolysaccharidosis IIIB Mouse Model by Adeno-associated Virus-Mediated Gene Delivery

    Neurological Correction of Lysosomal Storage in a Mucopolysaccharidosis IIIB Mouse Model by Adeno-associated Virus-Mediated Gene Delivery -н Haiyan Fu, R. Jude Samulski, Thomas J. McCown, Yoana J. Picornell, David Fletcher, Joseph Muenzer

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    PO-0096 Clinical Effectiveness Of Idursulfase In Boys Aged 0–5 Years With Hunter Syndrome: 3-year Data From The Hunter Outcome Survey

    PO-0096 Clinical Effectiveness Of Idursulfase In Boys Aged 0–5 Years With Hunter Syndrome: 3-year Data From The Hunter Outcome Survey -н Joseph Muenzer, Roberto Giugliani, Maurizio Scarpa, Akemi Tanaka, A Anna Tylki-Szymanska, Isabelle Morin, Michael Beck

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

    Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain -н Haiyan Fu, Joseph Muenzer, R. Jude Samulski, George R. Breese, Jerillyn Sifford, Xinhua Zeng, Douglas M. McCarty

    Хэвлэсэн 2003
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey

    Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey -н Joseph Muenzer, Michael Beck, Roberto Giugliani, Yasuyuki Suzuki, Anna Tylki‐Szymańska, Vassili Valayannopoulos, Ashok Vellodi, J. E. Wraith

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide -н Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Safety and Feasibility of High-pressure Transvenous Limb Perfusion With 0.9% Saline in Human Muscular Dystrophy

    Safety and Feasibility of High-pressure Transvenous Limb Perfusion With 0.9% Saline in Human Muscular Dystrophy -н Zheng Fan, Keith C. Kocis, Robert D. Valley, James F. Howard, Manisha Chopra, Hongyu An, Weili Lin, Joseph Muenzer, William J. Powers

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: